All Insights
Showing 565 - 576 of 1929
Life Sciences and Healthcare
EU enforces stricter liability for life sciences products
Pharma and medtech companies face enhanced liability under the EU's new directive
Business crime
Failure to prevent fraud: steps to take before September 2025
What does new guidance say about the failure to prevent fraud offence entering into force in nine months?
Retail and Consumer
Black Friday and competition law: compliance top tips and errors to avoid in the UK and EU
Retailers and brands must also navigate competition law and sustainability concerns around the November shopping event
Life Sciences and Healthcare
Medtech sector faces new EU 'green deal' recommendations
Greener medical devices and processes are among MedTech Europe's recommendations for business sustainability
Real estate
Housebuilding market study: UK government responds to CMA proposals
Broad acceptance of recommendations to improve the housebuilding market confirmed by UK government, with detail awaited
Regulatory and compliance
Are you prepared for the forthcoming changes on prompt payment terms for public tendering in the UK?
Failure to comply with measures will mean companies cannot participate in central government procurements over £5 million
ESG Knowledge Update | November 2024
Welcome to our Osborne Clarke ESG Knowledge Update, which offers a round-up of legal, regulatory and market news
Life Sciences and Healthcare
Life sciences dealmakers need to anticipate sector-specific factors in European M&A
European regulatory and intellectual property complexities must be addressed when engaging in mergers and acquisitions
Future-proofing supply chains
Sustainable supply chains drive international success, GC summit hears
Global compliance will continue to get more complicated for international businesses and their GCs
Financial Services
UK Financial Conduct Authority launches premium finance market study
The regulator is assessing whether there is adequate competition in the market and fair value for consumers
Corporate
UK Takeover Panel confirms refocusing of the scope of City Code
Finalised amendments to the jurisdictional framework of the Takeover Code will streamline its applicability
Life Sciences and Healthcare
UK government to refresh post-market surveillance requirements for medical devices
New regulations introduced to bring the UK regulatory framework closer in line with international best practice for post-market surveillance requirements
